公开(公告)号：US20200254002A1

公开(公告)日：2020-08-13

申请号：US16649320

申请日：2018-09-28

申请人： SAREPTA THERAPEUTICS, INC. ,  CATABASIS PHARMACEUTICALS, INC.

发明人： Marco A. PASSINI ,  Jill C. MILNE ,  Andrew J. NICHOLS

IPC分类号： A61K31/7125 ,  A61P21/00

摘要： The present disclosure relates to methods of treating Duchenne's Muscular Dystrophy by administering an antisense oligonucleotide that induces exon skipping and a non-steroidal anti-inflammatory compound.

公开(公告)号：US20200248178A1

公开(公告)日：2020-08-06

申请号：US16649565

申请日：2018-09-28

申请人： Sarepta Therapeutics, Inc. ,  Catabasis Pharmaceuticals, Inc.

发明人： Marco A. PASSINI ,  Jill C. MILNE ,  Andrew J. NICHOLS

IPC分类号： C12N15/113 ,  A61K31/166 ,  A61P29/00

摘要： The present disclosure relates to methods of treating Duchenne's Muscular Dystrophy by administering an antisense oligonucleotide that induces exon skipping and a non-steroidal anti-inflammatory compound.

公开(公告)号：US20210145852A1

公开(公告)日：2021-05-20

申请号：US16649521

申请日：2018-09-28

申请人： Sarepta Therapeutics, Inc. ,  Catasis Pharmaceuticals Inc.

发明人： Marco A. PASSINI ,  Jill C. MILNE ,  Andrew J. NICHOLS

IPC分类号： A61K31/675 ,  A61P21/00 ,  A61K31/166

摘要： The present disclosure relates to methods of treating Duchenne's Muscular Dystrophy by administering an antisense oligonucleotide that induces exon skipping and a non-steroidal anti-inflammatory compound.